ÂÜÀòÂÒÂ×

Emily Brennan has a diverse work experience in the field of biotechnology. Emily started their career at Claritas Genomics as a Molecular Technologist from November 2014 to January 2018. Following that, they joined Editas Medicine as a Research Associate from February 2018 to August 2021. Currently, they are employed at Beam Therapeutics, where they first worked as a Senior Research Associate I from August 2021 to September 2023, and now holds the position of a Principal Research Associate from August 2023 onwards.

Emily Brennan has a Bachelor's degree in Biochemistry from Stony Brook University, obtained from 2010 to 2014. Emily also holds a certification as a Technologist in Molecular Biology from the American Society for Clinical Pathology (ASCP), obtained in August 2017.